Authors:
Comba, AZ
Blajman, C
Richardet, E
Bella, S
Vilanova, M
Coppola, F
Van Kooten, M
Rodger, J
Giglio, R
Balbiani, L
Perazzo, F
Montiel, M
Chacon, M
Pujol, F
Mickiewicz, E
Cazap, E
Recondo, G
Lastiri, F
Simon, J
Wasserman, E
Schmilovich, A
Citation: Az. Comba et al., A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previouslyuntreated metastatic colorectal cancer patients, EUR J CANC, 37(8), 2001, pp. 1006-1013
Authors:
Marantz, A
Jovtis, S
Almira, E
Balbiani, L
Castilla, JL
Fein, L
Lewi, D
Pasccon, G
Pinckevicius, R
Uranga, G
Abal, M
Muino, M
Reale, M
Agusto, S
Lastiri, F
Citation: A. Marantz et al., Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer, SEMIN ONCOL, 28(3), 2001, pp. 44-49
Authors:
Casassus, P
Gibson, J
Joshua, DE
Matthews, J
Diaz, JC
Gertz, MA
Kyle, R
Leong, T
Oken, MM
Fritz, E
Ludwig, H
Corrado, C
Lastiri, F
Peest, D
Grosbois, B
Vela-Ojeda, J
Avvisati, G
Mandelli, F
Petrucci, MT
Capnist, G
Child, JA
Drayson, MT
Dunn, J
MacLennan, I
Mellstedt, H
Osterborg, A
Rodjer, S
Turesson, I
Westin, J
Bergsagel, D
Browman, GP
Shustik, C
Zee, B
Hjorth, M
Holmberg, E
Rodjer, S
Turesson, I
Westin, J
Alison, R
Clarke, M
Elphinstone, P
Evans, V
Gray, R
Hicks, C
James, S
MacKinnon, L
Peto, R
Richards, S
Wheatley, K
Blade, J
Fontanillas, M
San Miguel, J
Aitchison, R
Newland, AC
Cunningham, D
Malpas, J
Powles, RL
Montuoro, A
Jacobson, J
Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Citation: M. Marengo et al., Hormonal replacement therapy with percutaneous estradiol and oral progesterone. Three years follow-up of a combined 25-days/calendar month schedule, 9TH INTERNATIONAL MENOPAUSE SOCIETY WORLD CONGRESS ON THE MENOPAUSE, 1999, pp. 205-208